Drug Use Investigation for Toviaz

• Status: Completed
• Trial end date: 2016-05-19
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to collect effectiveness and safety information of fesoterodine related to their appropriate use in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Fesoterodine

Criteria

Inclusion Criteria:

• Patients prescribed fesoterodine (Toviaz).

Exclusion Criteria:

• There are no exclustion criteria